Investigators, as we might expect, are concerned about financial issues, ranging from developing accurate forecasts to cash flow. In fact this is their greatest general area of discomfort. We know that next to the desire to participate in medically innovative research, financial remuneration is the most important reason these What bothers clinical investigators? A new survey of more than 1,000 clinical trials investigators working in the US reveals some predictable and some surprising concerns regarding their ability to function in an increasingly costly and complex trials environment, reports Harold E Glass Clinical Trials.
Yet many clinical sites are not comfortable with their ability to develop study budgets or track actual costs against those budgets. Nearly one-third of the sites have difficulty tracking costs against a budget. A slightly smaller number of sites point to their difficulties in developing an accurate study budget against which to track actual costs. A quarter of sites are bothered about the timely collection of invoices against milestones Clinical Trials.